AEYE vs. ADMA
AEYE (AudioEye, Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. AEYE operates in Software - Application (Technology), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, AEYE returned 6.08%/yr vs 3.08%/yr for ADMA. At a 0.11 correlation, their price movements are largely independent.
Performance
AEYE vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AEYE achieves a -27.73% return, which is significantly higher than ADMA's -49.78% return. Over the past 10 years, AEYE has outperformed ADMA with an annualized return of 6.08%, while ADMA has yielded a comparatively lower 3.08% annualized return.
AEYE
- 1D
- -2.56%
- 1M
- 7.28%
- 6M
- -25.10%
- YTD
- -27.73%
- 1Y
- -41.44%
- 3Y*
- 14.10%
- 5Y*
- -15.08%
- 10Y*
- 6.08%
ADMA
- 1D
- -0.54%
- 1M
- 13.65%
- 6M
- -51.33%
- YTD
- -49.78%
- 1Y
- -48.57%
- 3Y*
- 36.39%
- 5Y*
- 43.60%
- 10Y*
- 3.08%
AEYE vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AEYE AudioEye, Inc. | -27.73% | -34.32% | 180.63% | 41.51% | -45.44% | -72.82% | 450.75% | -45.15% | 128.00% | 7.14% |
ADMA ADMA Biologics, Inc. | -49.78% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
Correlation
The correlation between AEYE and ADMA is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.11 |
Fundamentals
AEYE:
$90.20M
ADMA:
$2.12B
AEYE:
-$0.30
ADMA:
$0.68
AEYE:
2.18
ADMA:
4.36
AEYE:
28.30
ADMA:
5.63
AEYE:
$41.13M
ADMA:
$509.86M
AEYE:
$32.07M
ADMA:
$312.42M
AEYE:
-$1.08M
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AEYE vs. ADMA — Risk / Return Rank
AEYE
ADMA
AEYE vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AudioEye, Inc. (AEYE) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AEYE | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.24 | ||
| Sortino ratioReturn per unit of downside risk | +0.46 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 0.84 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.64 | -0.78 | +0.14 |
| Martin ratioReturn relative to average drawdown | -1.05 | -1.45 | +0.41 |
Loading charts...
Drawdowns
AEYE vs. ADMA - Drawdown Comparison
The maximum AEYE drawdown since its inception was -97.86%, which is greater than ADMA's maximum drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for AEYE and ADMA.
Loading charts...
Drawdown Indicators
| AEYE | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.86% | -91.28% | -6.58% |
Max Drawdown (1Y)Largest decline over 1 year | -64.87% | -62.71% | -2.16% |
Max Drawdown (3Y)Largest decline over 3 years | -83.95% | -68.99% | -14.96% |
Max Drawdown (5Y)Largest decline over 5 years | -83.95% | -68.99% | -14.96% |
Max Drawdown (10Y)Largest decline over 10 years | -92.81% | -86.11% | -6.70% |
Current DrawdownCurrent decline from peak | -83.47% | -62.63% | -20.84% |
Average DrawdownAverage peak-to-trough decline | -76.14% | -53.10% | -23.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.65% | 33.41% | +6.24% |
Volatility
AEYE vs. ADMA - Volatility Comparison
AudioEye, Inc. (AEYE) has a higher volatility of 19.84% compared to ADMA Biologics, Inc. (ADMA) at 10.00%. This indicates that AEYE's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AEYE | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.84% | 10.00% | +9.84% |
Volatility (6M)Calculated over the trailing 6-month period | 51.27% | 45.91% | +5.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.18% | 54.28% | +8.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.44% | 59.45% | +22.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 104.42% | 68.98% | +35.44% |
Dividends
AEYE vs. ADMA - Dividend Comparison
Neither AEYE nor ADMA has paid dividends to shareholders.
Financials
AEYE vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between AudioEye, Inc. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AEYE vs. ADMA - Profitability Comparison
AEYE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, AudioEye, Inc. reported a gross profit of 8.25M and revenue of 10.55M. Therefore, the gross margin over that period was 78.2%.
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
AEYE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, AudioEye, Inc. reported an operating income of -1.88M and revenue of 10.55M, resulting in an operating margin of -17.8%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
AEYE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, AudioEye, Inc. reported a net income of -2.11M and revenue of 10.55M, resulting in a net margin of -20.0%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
Frequently Asked Questions
AEYE and ADMA have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AEYE has higher volatility (19.84%) compared to ADMA (10.00%). In terms of maximum drawdown, AEYE dropped -97.86% vs ADMA's -91.28%.
AEYE currently has the higher Sharpe Ratio (-0.66 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AEYE and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer